Robert E. Funck, Executive Vice President & CFO at ABBOTT LABORATORIES (ABT), sold 166,666 shares at $108.83 ($18.1M) on 2020-10-26, disclosed to the SEC on 2020-10-28.
Open-market sale of $18.1M ABT by Executive Vice President & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.83 | 83,333 | $9.1M | 50.0% |
| 2 | $108.83 | 83,333 | $9.1M | 50.0% |
| Total | $108.83 avg | 166,666 | $18.1M | 100% |
| Filing → |
| ABT | SELL | 2018-03-02 | $144K | — | Filing → |
| ABT | SELL | 2017-02-24 | $1.2M | — | Filing → |
| ABT | SELL | 2016-07-27 | $1.2M | — | Filing → |